Department of Pharmaceuticals

Polity & Governance glossary

Also called: DoP · Topic: Statutory, Regulatory and Quasi-judicial Bodies · NCERT: Beyond NCERT

Meaning

The Department of Pharmaceuticals (DoP) is a department of the Union government under the Ministry of Chemicals and Fertilizers. Its job is to help the medicine and medical-device industries grow in India. It is an executive unit of a ministry, so no separate Act or constitutional article created it. It runs production-linked incentive (PLI) schemes, where firms are paid according to what they actually make in India, not given money upfront. It matters because cutting India's import dependence in medicines and devices is a goal of Atmanirbhar Bharat and Make in India.

Example

In March 2020, DoP launched the PLI Scheme for Promoting Domestic Manufacturing of Medical Devices with an outlay of ₹3,420 crore. In November 2026 it opened PLI-MD 2.0. This round extends the scheme up to 2035–36, has about ₹2,700 crore available and has simpler entry rules. DoP also brought out the National Medical Devices Policy, 2023, which aims to grow the sector from US$11 billion to US$50 billion.

Don't confuse with

  • Ministry of Health and Family Welfare / CDSCO: these handle health and the quality and safety of devices. DoP handles industrial promotion, which means helping firms make more. PLI-MD is run by DoP, not the Health Ministry.
  • Statutory regulator: a body such as FSSAI or SEBI is set up by an Act and kept at a distance from the government. DoP is part of the government itself.

Read more